Mark Alles

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 78% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mark Alles's trades of Biomarin Pharmaceutical Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
357.76
Quantity 9,373 +4.7%
Value US$220,641
Transaction date
Purchase
Price
142.39
Quantity 37,834 -42.2%
Value US$3,451,092
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-02 2022-10-31
B Purchase
9,373 +4.7%
357.76
US$220,641 		9,373 +4.7% 357.76 US$220,641
2020-05-13 2020-05-13
B Purchase
37,834 -42.2%
142.39
US$3,451,092 		37,834 -42.2% 142.39 US$3,451,092